Imitrex and Artery dissection - a phase IV clinical study of FDA data

Summary:

Artery dissection is reported as a side effect among people who take Imitrex (sumatriptan succinate), especially for people who are female, 30-39 old, also take Accutane, and have Birth control.

The phase IV clinical study analyzes which people have Artery dissection when taking Imitrex. It is created by eHealthMe based on reports of 15,815 people who have side effects when taking Imitrex from the FDA, and is updated regularly.

What is Imitrex?

Imitrex has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 17,149 Imitrex users. Check the latest studies of Imitrex.

What is Artery dissection?

Artery dissection is found to be associated with 53 drugs and 174 conditions by eHealthMe. Check the latest studies of Artery dissection.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 20, 2026

15,815 people reported to have side effects when taking Imitrex.
Among them, 12 people (0.08%) have Artery dissection.

Among these 12 people:

What is the gender of people who have Artery dissection when taking Imitrex? *

female: 100 %
male: 0.0 %

What is the age of people who have Artery dissection when taking Imitrex? *

What are other drugs people take besides Imitrex? *

Zelnorm: 5 people, 41.67%
Ortho Evra: 5 people, 41.67%
Accutane: 5 people, 41.67%
Rabeprazole Sodium: 3 people, 25.00%

What are other side effects people have besides Artery dissection? *

White Blood Cell Count Increased: 5 people, 41.67%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 5 people, 41.67%
Fatigue (feeling of tiredness): 5 people, 41.67%
Extrasystoles: 5 people, 41.67%
Electrocardiogram T Wave Abnormal: 5 people, 41.67%
Electrocardiogram St Segment Elevation: 5 people, 41.67%
Electrocardiogram Qt Prolonged: 5 people, 41.67%
Dyspnea (difficult or laboured breathing): 5 people, 41.67%
Dizziness: 5 people, 41.67%
Coronary Artery Dilatation: 5 people, 41.67%

What are the existing conditions these people have? *

Irritable Bowel Syndrome: 5 people, 41.67%
Birth Control: 5 people, 41.67%
Acne (skin problems that cause pimples): 4 people, 33.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 25.00%
Basal Cell Carcinoma (a skin cancer, it rarely metastasizes or kills): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Imitrex and have Artery dissection?

- Check whether Artery dissection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Imitrex:

Imitrex (17,149 reports)

Browse all side effects of Imitrex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Artery dissection:

Artery dissection (53 drugs)

Browse all the conditions that are associated with Artery dissection:

Artery dissection (174 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sumatriptan succinate (the active ingredients of Imitrex) and Imitrex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.